Direct renin inhibition in a rat model of chronic allograft injury

Keyphrases

• Rat Model 100%
• Aliskiren 100%
• Chronic Allograft Injury 100%
• Direct Renin Inhibition 100%
• Angiotensin II (Ang II) 75%
• Candesartan 75%
• Renin-angiotensin System Inhibitors 75%
• Chronic Allograft Dysfunction 75%
• Angiotensin-(1-7) 75%
• Proteinuria 50%
• Breakdown Products 50%
• Renin-angiotensin System 50%
• Angiotensin Receptor Blockers 50%
• Urinary Angiotensinogen 50%
• Kidney 25%
• Myofibroblast 25%
• Renal Function 25%
• Chronic Kidney Disease 25%
• Collagen Deposition 25%
• Morphological Changes 25%
• Creatinine Clearance 25%
• Angiotensin-converting Enzyme 25%
• Angiotensin-converting Enzyme 2 (ACE2) 25%
• Transplantation 25%
• Seven-level 25%
• Tubular Cells 25%
• Renin 25%
• Macrophage Infiltration 25%
• Renal Transplantation 25%
• Glomerulosclerosis 25%
• Renoprotective Effect 25%
• Hand Atrophy 25%
• Transplantation Model 25%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Rat Model 100%
• Renin Inhibitor 100%
• Aliskiren 100%
• Renin 100%
• Angiotensin II 75%
• Candesartan 75%
• angiotensin[1-7] 75%
• Angiotensin 75%
• Angiotensin Receptor Antagonist 50%
• Angiotensinogen 50%
• Proteinuria 50%
• Kidney Disease 25%
• Creatinine 25%
• Dipeptidyl Carboxypeptidase Inhibitor 25%
• Dipeptidyl Carboxypeptidase 25%
• Glomerulosclerosis 25%